Cargando…

CXCR4 Antagonists as Stem Cell Mobilizers and Therapy Sensitizers for Acute Myeloid Leukemia and Glioblastoma?

Glioblastoma is the most aggressive and malignant primary brain tumor in adults and has a poor patient survival of only 20 months after diagnosis. This poor patient survival is at least partly caused by glioblastoma stem cells (GSCs), which are slowly-dividing and therefore therapy-resistant. GSCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hira, Vashendriya V.V., Van Noorden, Cornelis J.F., Molenaar, Remco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168055/
https://www.ncbi.nlm.nih.gov/pubmed/32079173
http://dx.doi.org/10.3390/biology9020031

Ejemplares similares